Financiën Thermo Fisher Scientific Inc.

Aandelen

TMO

US8835561023

Geavanceerde medische apparatuur & technologie

Beurs gesloten - Nyse Andere beurzen 22:00:02 09-09-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
620,42 ^USD	+1,49%		+0,87%	+16,89%

05/09	Transcript : Thermo Fisher Scientific Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 08:30 AM
06/08	FDA geeft Thermo Fisher Scientific Inc.'s SeCore HLA-typingset 510(k) goedkeuring voor gebruik als gezelschapsdiagnosticum met een T-Cell Receptor therapie voor synoviaal sarcoom	CI

Voorlopige winst- en verliesrekening: Thermo Fisher Scientific Inc.

Fiscaal tijdperk: december	2019	2020	2021	2022	2023	2024	2025	2026
Omzet ¹	25.542	32.218	39.211	44.915	42.857	42.937	45.688	48.985
Variatie	-	26,14%	21,71%	14,55%	-4,58%	0,19%	6,41%	7,22%
EBITDA ¹	6.537	10.214	12.969	11.971	10.878	10.791	11.736	12.896
Variatie	-	56,25%	26,97%	-7,7%	-9,13%	-0,8%	8,76%	9,88%
Bedrijfsresultaat (EBIT) ¹	5.973	9.556	12.138	10.985	9.810	9.696	10.571	11.524
Variatie	-	59,99%	27,02%	-9,5%	-10,7%	-1,16%	9,02%	9,01%
Betaalde rente ¹	-676	-553	-536	-726	-1.375	-1.375	-1.270	-1.039
Resultaat voor belastingen (EBT) ¹	4.070	7.225	8.841	7.835	6.298	6.835	7.772	9.112
Variatie	-	77,52%	22,37%	-11,38%	-19,62%	8,53%	13,71%	17,23%
Nettowinst (verlies) ¹	3.696	6.375	7.725	6.950	5.995	6.142	6.925	8.039
Variatie	-	72,48%	21,18%	-10,03%	-13,74%	2,45%	12,75%	16,09%
Datum van publicatie	30-01-20	01-02-21	02-02-22	01-02-23	31-01-24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: december	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2
Omzet ¹	6.272	6.829	6.230	6.917	8.521	10.550	9.906	9.273	9.330	10.702	11.818	10.970	10.677	11.450	10.710	10.687	10.574	10.886	10.345	10.541	10.646	11.359	10.958	11.229	11.346	12.116	11.755	12.016
Variatie	-	8,88%	-8,77%	11,03%	23,19%	23,81%	-6,1%	-6,39%	0,61%	14,71%	10,43%	-7,18%	-2,67%	7,24%	-6,46%	-0,21%	-1,06%	2,95%	-4,97%	1,89%	1%	6,7%	-3,53%	2,47%	1,05%	6,78%	-2,98%	2,23%
EBITDA ¹	1.564	1.846	1.526	2.021	2.964	3.703	3.708	2.900	2.983	3.378	3.700	2.841	2.614	2.816	2.583	2.640	2.829	2.826	2.564	2.623	2.636	2.939	2.775	2.845	2.916	3.197	2.963	3.085
Variatie	-	18,03%	-17,33%	32,44%	46,66%	24,93%	0,14%	-21,79%	2,86%	13,24%	9,53%	-23,22%	-7,99%	7,73%	-8,27%	2,21%	7,16%	-0,11%	-9,27%	2,3%	0,5%	11,5%	-5,57%	2,49%	2,5%	9,66%	-7,33%	4,12%
Bedrijfsresultaat (EBIT) ¹	1.423	1.698	1.377	1.864	2.803	3.512	3.510	2.689	2.778	3.161	3.450	2.605	2.370	2.560	2.330	2.370	2.560	2.550	2.278	2.347	2.371	2.691	2.496	2.575	2.631	2.893	2.672	2.796
Variatie	-	19,33%	-18,9%	35,37%	50,38%	25,29%	-0,06%	-23,39%	3,31%	13,79%	9,14%	-24,49%	-9,02%	8,02%	-8,98%	1,72%	8,02%	-0,39%	-10,67%	3,03%	1,03%	13,48%	-7,24%	3,16%	2,19%	9,93%	-7,61%	4,61%
Charge d'intérêts ¹	-164	-142	-126	-137	-144	-146	-125	-122	-128	-161	-136	-148	-173	-269	-300	-326	-359	-390	-363	-354	-331	-327	-304,8	-294,8	-282,4	-271,8	-174	-171
Resultaat voor belastingen (EBT) ¹	-	-	-	-	2.252	-	-	2.047	2.173	1.862	2.540	1.917	1.601	1.777	1.363	1.430	1.765	1.740	1.589	1.765	1.674	1.770	1.645	1.765	1.896	2.264	1.857	2.020
Variatie	-	-	-	-	-	-100%	-	-	6,16%	-14,31%	36,41%	-24,53%	-16,48%	10,99%	-23,3%	4,92%	23,43%	-1,42%	-8,68%	11,08%	-5,18%	5,77%	-7,06%	7,29%	7,42%	19,41%	-17,98%	8,78%
Nettowinst (verlies) ¹	760	1.002	788	1.156	1.933	2.498	2.337	1.828	1.902	1.658	2.215	1.664	1.495	1.576	1.289	1.361	1.715	1.630	1.328	1.548	1.471	1.652	1.447	1.555	1.672	2.002	1.637	1.784
Variatie	-	31,84%	-21,36%	46,7%	67,21%	29,23%	-6,45%	-21,78%	4,05%	-12,83%	33,59%	-24,88%	-10,16%	5,42%	-18,21%	5,59%	26,01%	-4,96%	-18,53%	16,57%	-4,95%	12,27%	-12,41%	7,46%	7,52%	19,74%	-18,23%	8,98%
Datum van publicatie	23-10-19	30-01-20	22-04-20	22-07-20	21-10-20	01-02-21	29-04-21	28-07-21	27-10-21	02-02-22	28-04-22	28-07-22	26-10-22	01-02-23	26-04-23	26-07-23	25-10-23	31-01-24	24-04-24	24-07-24	-	-	-	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Thermo Fisher Scientific Inc.

Fiscaal tijdperk: december	2019	2020	2021	2022	2023	2024	2025	2026
Nettoschuld ¹	15.353	11.410	30.393	25.964	26.840	24.152	19.322	11.706
Variatie	-	-25,68%	166,37%	-14,57%	3,37%	-10,01%	-20%	-39,42%
Datum van publicatie	30-01-20	01-02-21	02-02-22	01-02-23	31-01-24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Thermo Fisher Scientific Inc.

Fiscaal tijdperk: december	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	926	1.474	2.523	2.243	1.479	1.474	1.622	1.750
Variatie	-	59,18%	71,17%	-11,1%	-34,06%	-0,32%	10,04%	7,85%
Vrije kasstroom (FCF) ¹	4.047	6.815	7.020	6.935	6.927	6.791	8.564	9.476
Variatie	-	68,4%	3,01%	-1,21%	-0,12%	-1,97%	26,12%	10,64%
Datum van publicatie	30-01-20	01-02-21	02-02-22	01-02-23	31-01-24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Thermo Fisher Scientific Inc.

Fiscaal tijdperk: december	2019	2020	2021	2022	2023	2024	2025	2026
Winstgevendheid
EBITDA-marge (%)	25,59%	31,7%	33,07%	26,65%	25,38%	25,13%	25,69%	26,33%
EBIT-marge (%)	23,39%	29,66%	30,96%	24,46%	22,89%	22,58%	23,14%	23,53%
EBT-marge (%)	15,93%	22,43%	22,55%	17,44%	14,7%	15,92%	17,01%	18,6%
Nettomarge (%)	14,47%	19,79%	19,7%	15,47%	13,99%	14,3%	15,16%	16,41%
FCF-marge (%)	15,84%	21,15%	17,9%	15,44%	16,16%	15,82%	18,75%	19,34%
Vrije kasstroom/nettoresultaat (%)	109,5%	106,9%	90,87%	99,78%	115,55%	110,57%	123,67%	117,87%
Winstgevendheid
ROA	8,7%	12,26%	9,43%	9,52%	8,54%	7,62%	8,46%	8,65%
ROE	17,38%	24,34%	26,52%	21,61%	18,43%	17,24%	17,6%	17,73%
Financiële gezondheid
Hefboom (schuld/ebitda)	2,35x	1,12x	2,34x	2,17x	2,47x	2,24x	1,65x	0,91x
Schuld/vrije kasstroom	3,79x	1,67x	4,33x	3,74x	3,87x	3,56x	2,26x	1,24x
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	3,63%	4,58%	6,43%	4,99%	3,45%	3,43%	3,55%	3,57%
CAPEX / EBITDA (%)	14,17%	14,43%	19,45%	18,74%	13,6%	13,66%	13,82%	13,57%
CAPEX / FCF (%)	22,88%	21,63%	35,94%	32,34%	21,35%	21,71%	18,94%	18,47%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	12,34	20,77	24,04	23,23	21,66	22,16	28,12	30,52
Variatie	-	68,35%	15,71%	-3,35%	-6,75%	2,26%	26,9%	8,54%
Dividend per aandeel ¹	0,76	0,88	1,04	1,2	1,4	1,489	1,574	1,725
Variatie	-	15,79%	18,18%	15,38%	16,67%	6,35%	5,73%	9,6%
Nettoactief per aandeel ¹	74,19	86,48	103,4	112,6	120,9	128	137,5	154,8
Variatie	-	16,57%	19,58%	8,89%	7,33%	5,89%	7,43%	12,57%
WPA ¹	9,17	15,96	19,46	17,63	15,45	16,11	18,43	21,42
Variatie	-	74,05%	21,93%	-9,4%	-12,37%	4,3%	14,38%	16,2%
Aantal aandelen (in duizend)	400.991	396.335	394.048	394.048	386.372	381.996	381.996	381.996
Datum van publicatie	30-01-20	01-02-21	02-02-22	01-02-23	31-01-24	-	-	-